161 related articles for article (PubMed ID: 34344239)
21. New, highly active nonbenzoquinone geldanamycin derivatives by using mutasynthesis.
Eichner S; Floss HG; Sasse F; Kirschning A
Chembiochem; 2009 Jul; 10(11):1801-5. PubMed ID: 19554593
[No Abstract] [Full Text] [Related]
22. Conformational significance of EH21A1-A4, phenolic derivatives of geldanamycin, for Hsp90 inhibitory activity.
Onodera H; Kaneko M; Takahashi Y; Uochi Y; Funahashi J; Nakashima T; Soga S; Suzuki M; Ikeda S; Yamashita Y; Rahayu ES; Kanda Y; Ichimura M
Bioorg Med Chem Lett; 2008 Mar; 18(5):1588-91. PubMed ID: 18243703
[TBL] [Abstract][Full Text] [Related]
23. Development of 17-allylamino-17-demethoxygeldanamycin hydroquinone hydrochloride (IPI-504), an anti-cancer agent directed against Hsp90.
Sydor JR; Normant E; Pien CS; Porter JR; Ge J; Grenier L; Pak RH; Ali JA; Dembski MS; Hudak J; Patterson J; Penders C; Pink M; Read MA; Sang J; Woodward C; Zhang Y; Grayzel DS; Wright J; Barrett JA; Palombella VJ; Adams J; Tong JK
Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17408-13. PubMed ID: 17090671
[TBL] [Abstract][Full Text] [Related]
24. Geldanamycin-Derived HSP90 Inhibitors Are Synthetic Lethal with NRF2.
Baird L; Suzuki T; Takahashi Y; Hishinuma E; Saigusa D; Yamamoto M
Mol Cell Biol; 2020 Oct; 40(22):. PubMed ID: 32868290
[TBL] [Abstract][Full Text] [Related]
25. Drug-mediated targeted disruption of multiple protein activities through functional inhibition of the Hsp90 chaperone complex.
Stravopodis DJ; Margaritis LH; Voutsinas GE
Curr Med Chem; 2007; 14(29):3122-38. PubMed ID: 18220746
[TBL] [Abstract][Full Text] [Related]
26. Biosynthesis of Novel Glucosides Geldanamycin Analogs by Enzymatic Synthesis.
Huo Q; Li HM; Lee JK; Li J; Ma T; Zhang X; Dai Y; Hong YS; Wu CZ
J Microbiol Biotechnol; 2016 Jan; 26(1):56-60. PubMed ID: 26464380
[TBL] [Abstract][Full Text] [Related]
27. Cystine-glutamate transporter SLC7A11 mediates resistance to geldanamycin but not to 17-(allylamino)-17-demethoxygeldanamycin.
Liu R; Blower PE; Pham AN; Fang J; Dai Z; Wise C; Green B; Teitel CH; Ning B; Ling W; Lyn-Cook BD; Kadlubar FF; Sadée W; Huang Y
Mol Pharmacol; 2007 Dec; 72(6):1637-46. PubMed ID: 17875604
[TBL] [Abstract][Full Text] [Related]
28. 17-DMCHAG, a new geldanamycin derivative, inhibits prostate cancer cells through Hsp90 inhibition and survivin downregulation.
Wang J; Li Z; Lin Z; Zhao B; Wang Y; Peng R; Wang M; Lu C; Shi G; Shen Y
Cancer Lett; 2015 Jun; 362(1):83-96. PubMed ID: 25813406
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological evaluation of geldanamycin analogs against human cancer cells.
Li YP; Chen JJ; Shen JJ; Cui J; Wu LZ; Wang Z; Li ZR
Cancer Chemother Pharmacol; 2015 Apr; 75(4):773-82. PubMed ID: 25681003
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis and biological evaluation of novel aliphatic amido/sulfonamido-quaternary ammonium salts as antitumor agents.
Song D; Yang JS; Kim SJ; Kim BK; Park SK; Won M; Lee K; Kim HM; Choi KY; Lee K; Han G
Bioorg Med Chem; 2013 Feb; 21(3):788-94. PubMed ID: 23266181
[TBL] [Abstract][Full Text] [Related]
31. Discovery and development of heat shock protein 90 inhibitors as anticancer agents: a review of patented potent geldanamycin derivatives.
Kim T; Keum G; Pae AN
Expert Opin Ther Pat; 2013 Aug; 23(8):919-43. PubMed ID: 23641970
[TBL] [Abstract][Full Text] [Related]
32. New geldanamycin analogs from Streptomyces hygroscopicus.
Wu CZ; Jang JH; Ahn JS; Hong YS
J Microbiol Biotechnol; 2012 Nov; 22(11):1478-81. PubMed ID: 23124337
[TBL] [Abstract][Full Text] [Related]
33. 17-ABAG, a novel geldanamycin derivative, inhibits LNCaP-cell proliferation through heat shock protein 90 inhibition.
Lin Z; Peng R; Li Z; Wang Y; Lu C; Shen Y; Wang J; Shi G
Int J Mol Med; 2015 Aug; 36(2):424-32. PubMed ID: 26059743
[TBL] [Abstract][Full Text] [Related]
34. Delivery of HSP90 Inhibitor Using Water Soluble Polymeric Conjugates with High Drug Payload.
Suárez Del Pino JA; Kolhatkar R
Pharm Res; 2017 Dec; 34(12):2735-2748. PubMed ID: 28913790
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis, and biological evaluation of hydroquinone derivatives of 17-amino-17-demethoxygeldanamycin as potent, water-soluble inhibitors of Hsp90.
Ge J; Normant E; Porter JR; Ali JA; Dembski MS; Gao Y; Georges AT; Grenier L; Pak RH; Patterson J; Sydor JR; Tibbitts TT; Tong JK; Adams J; Palombella VJ
J Med Chem; 2006 Jul; 49(15):4606-15. PubMed ID: 16854066
[TBL] [Abstract][Full Text] [Related]
36. Identification of 6-demethoxy-6-methylgeldanamycin and its implication of geldanamycin biosynthesis.
Ni S; Jiang B; Wu L; Wang Y; Zhou H; He W; Wang H; Zhu J; Li S; Li T; Zhang K
J Antibiot (Tokyo); 2014 Feb; 67(2):183-5. PubMed ID: 24105607
[No Abstract] [Full Text] [Related]
37. Enzymatic biosynthesis and biological evaluation of novel 17-AAG glucoside as potential anti-cancer agents.
Li HM; Li B; Sun X; Ma H; Zhu M; Dai Y; Ma T; Li Y; Hong YS; Wu CZ
Bioorg Med Chem Lett; 2020 Aug; 30(15):127282. PubMed ID: 32527461
[TBL] [Abstract][Full Text] [Related]
38. Synthetic ansamycins prepared by a ring-expanding Claisen rearrangement. Synthesis and biological evaluation of ring and conformational analogues of the Hsp90 molecular chaperone inhibitor geldanamycin.
McErlean CS; Proisy N; Davis CJ; Boland NA; Sharp SY; Boxall K; Slawin AM; Workman P; Moody CJ
Org Biomol Chem; 2007 Feb; 5(3):531-46. PubMed ID: 17252137
[TBL] [Abstract][Full Text] [Related]
39. Non-benzoquinone geldanamycin analogs trigger various forms of death in human breast cancer cells.
Zhang Z; Li HM; Zhou C; Li Q; Ma L; Zhang Z; Sun Y; Wang L; Zhang X; Zhu B; Hong YS; Wu CZ; Liu H
J Exp Clin Cancer Res; 2016 Sep; 35(1):149. PubMed ID: 27658586
[TBL] [Abstract][Full Text] [Related]
40. Anticancer effects of the Hsp90 inhibitor 17-demethoxy-reblastatin in human breast cancer MDA-MB-231 cells.
Zhao Q; Wu CZ; Lee JK; Zhao SR; Li HM; Huo Q; Ma T; Zhang J; Hong YS; Liu H
J Microbiol Biotechnol; 2014 Jul; 24(7):914-20. PubMed ID: 24705874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
